Breast Cancer Clinical Trial

Combined Breast Cancer Risk Study

Summary

A prospective, non-interventional study in women 18 to 84 years of age. Subjects will provide a sample for genetic testing and information about their medical and family history. The results of the genetic test will be combined with clinical data to validate a method of predicting breast cancer risk.

View Full Description

Full Description

This is a prospective, non- interventional study. Women presenting at imaging centers for routine breast cancer screening or breast cancer diagnostic assessment and who provide written informed consent will undergo genetic testing. Subjects will also provide information about their personal medical and cancer history and family cancer history. The results of the genetic test will be combined with the subject's clinical information, family history, and a risk assessment model to validate a new method of predicting breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women without breast cancer:

18 to 84 years of age
Western/Northern European, Central/Eastern European, or Ashkenazi ancestry
No history of invasive breast cancer

Women with a history of breast cancer:

18 to 84 years of age
Western/Northern European, Central/Eastern European, or Ashkenazi ancestry
Pathologically confirmed invasive breast cancer diagnosed within the past 12 months

Exclusion Criteria:

Unwilling to provide written informed consent
Women with history of ductal carcinoma in situ (DCIS).
Patient has had a prior breast biopsy, exclusive of a breast biopsy diagnostic of breast cancer, that showed either hyperplasia, atypical hyperplasia, lobular carcinoma in situ (LCIS), or the specific histologic result is unknown to the patient

Study is for people with:

Breast Cancer

Estimated Enrollment:

553

Study ID:

NCT03067389

Recruitment Status:

Completed

Sponsor:

Myriad Genetic Laboratories, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

The Breast Center of Northwest Arkansas
Fayetteville Arkansas, 72703, United States
Bethesda Health
Boynton Beach Florida, 33437, United States
Cuda Women's Health Center
Hyannis Massachusetts, 02601, United States
Elizabeth Wende Breast Care
Rochester New York, 14620, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

553

Study ID:

NCT03067389

Recruitment Status:

Completed

Sponsor:


Myriad Genetic Laboratories, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.